Press Releases about Pfizer
European Commission Approves Pfizer’s ELREXFIO® for Relapsed and Refractory Multiple Myeloma
December 08, 2023
From Pfizer Inc.
Via Business Wire
Pfizer Inc. (NYSE: PFE) is One of Friday Morning’s Most Active Stocks
December 01, 2023
Pneumococcal Pneumonia Can Be Life-Threatening. Here’s What to Know
November 15, 2023
Via StatePoint Media
Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes $200 Billion GLP-1 Market with its DehydraTECH(TM) Technology
November 14, 2023
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
MarketBeat Week in Review – 11/6 - 11/10
November 11, 2023
Via MarketBeat
GSK is a remedy for the winter investment blahs
November 07, 2023
Via MarketBeat
Topics
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.